Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
01 Jun 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/neotx-announces-successful-first-stage-completion-of-its-phase-2a-clinical-trial-of-naptumomab-estafenatox-nap-in-combination-with-docetaxel-in-advanced-non-small-cell-lung-cancer-nsclc-301558939.html
09 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/neotx-therapeutics-to-present-at-the-society-for-immunotherapy-of-cancers-36th-annual-meeting-301419547.html
20 Oct 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/neotx-announces-first-patient-enrolled-in-phase-2a-clinical-trial-of-naptumomab-estafenatox-nap-its-lead-tumor-targeted-superantigen-tts-candidate-in-combination-with-docetaxel-in-patients-with-advanced-non-small-cell-lung-c-301404001.html
07 Jul 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/07/07/2259408/0/en/NeoTX-Hosting-Key-Opinion-Leader-Webinar-on-Overcoming-Check-Point-Inhibitor-Resistance.html
20 Apr 2021
// PRESS RELEASE
https://www.pharmacompass.com/pdf/news/us-fda-clears-neotxs-ind-application-for-ph-2-trial-of-naptumomab-estafenatox-1622781642.pdf
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?